ResearcherFirst Affiliated Hospital Zhejiang UniversityActive in the last 2 years
Junming Huang
Matched on ORCID iD 0000-0002-6800-2788; OpenAlex author ID A5100685045. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 21
2022: 1 paper · 2023: 2 papers · 2024: none · 2025: 1 paper
Papers 4
- Targeting spermine metabolism to overcome immunotherapy resistance in pancreatic cancer. Co-author DOI 10.1038/s41467-025-63146-2↗
- In Situ Formed ROS-Responsive Hydrogel with STING Agonist and Gemcitabine to Intensify Immunotherapy against Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/adhm.202203264↗
- An Ionic Liquid Ablation Agent for Local Ablation and Immune Activation in Pancreatic Cancer. Co-author DOI 10.1002/advs.202206756↗
- Oncolytic peptide LTX-315 induces anti-pancreatic cancer immunity by targeting the ATP11B-PD-L1 axis. Co-author DOI 10.1136/jitc-2021-004129↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Qida Hu · 2 shared papers, 2023 · strength 0.39
- Shiyi Shao · 2 shared papers, 2023 · strength 0.39
- Tingbo Liang · 2 shared papers, 2022–2025 · strength 0.34
- Meng Wang · 1 shared paper, 2023 · strength 0.19
- Tingbo Liang · 1 shared paper, 2023 · strength 0.19
- Tingbo Liang · 1 shared paper, 2023 · strength 0.19
- Hanshen Yang · 1 shared paper, 2025 · strength 0.19
- Lihong He · 1 shared paper, 2025 · strength 0.19
- Lingyue Liu · 1 shared paper, 2025 · strength 0.19
- Xiongbin Lu · 1 shared paper, 2025 · strength 0.19
- Kang Sun · 1 shared paper, 2025 · strength 0.19
- Xinyuan Liu · 1 shared paper, 2025 · strength 0.19
- Yan Chen · 1 shared paper, 2025 · strength 0.19
- Xiaozhen Zhang · 1 shared paper, 2025 · strength 0.19
- Mengyi Lao · 1 shared paper, 2025 · strength 0.19
- Xueli Bai · 1 shared paper, 2025 · strength 0.19
- Zhengtao Hong · 1 shared paper, 2022 · strength 0.16
- Xiao Zhi · 1 shared paper, 2022 · strength 0.16
- Gang Zhang · 1 shared paper, 2022 · strength 0.16
- Xing Huang · 1 shared paper, 2022 · strength 0.16
- Tianyu Tang · 1 shared paper, 2022 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.